Comparative in vitro metabolism of benzo[a]pyrene by recombinant zebrafish CYP1A and liver microsomes from beta-naphthoflavone-treated rainbow trout
- Miranda, C.L., Chung, W.G., Wang-Buhler, J.L., Musafia-Jeknic, T., Baird, W.M., and Buhler, D.R.
- Aquatic toxicology (Amsterdam, Netherlands) 80(2): 101-108 (Journal)
- Registered Authors
- Buhler, Donald R., Chung, Won-Suk
- Zebrafish, Danio rerio, Cytochrome P450, CYP1A, DNA binding
- MeSH Terms
- Carbon Isotopes/analysis
- Cytochrome P-450 Enzyme System/metabolism*
- Microsomes, Liver/drug effects
- Microsomes, Liver/metabolism*
- Oncorhynchus mykiss/metabolism*
- Phosphorus Isotopes/analysis
- Protein Binding/drug effects
- Recombinant Proteins/metabolism*
- Saccharomyces cerevisiae
- Zebrafish Proteins/metabolism*
- 16963132 Full text @ Aquat. Toxicol.
Miranda, C.L., Chung, W.G., Wang-Buhler, J.L., Musafia-Jeknic, T., Baird, W.M., and Buhler, D.R. (2006) Comparative in vitro metabolism of benzo[a]pyrene by recombinant zebrafish CYP1A and liver microsomes from beta-naphthoflavone-treated rainbow trout. Aquatic toxicology (Amsterdam, Netherlands). 80(2):101-108.
The zebrafish (Danio rerio) is a sensitive non-mammalian model used for studying polycyclic aromatic hydrocarbon (PAH)-induced chemical carcinogenesis. The susceptibility of zebrafish to PAH-induced carcinogenesis may be related to the ability of the zebrafish P450s to bioactivate these procarcinogens. As a part of our overall effort to identify the various P450 enzymes that are involved in the activation and detoxification of PAHs in zebrafish, therefore, we have examined the ability of recombinant zebrafish CYP1A (zCYP1A) expressed in yeast to metabolize BaP in vitro. Comparison studies also were conducted with liver microsomes from beta-naphthoflavone (BNF)-treated rainbow trout (Oncorhynchus mykiss). Results demonstrated that the trout liver microsomes were almost twice as active as zCYP1A in oxidizing BaP, with V(max) values of 1.7 and 0.94nmol/min/nmol P450 for trout and zebrafish preparations, respectively. Like trout CYP1A1, cDNA-expressed zCYP1A was found to oxidize BaP to phenols, quinones and diols (BaP-7,8-diol and BaP-9,10-diol) in the presence of exogenous human microsomal epoxide hydrolase (hEH). BaP-7,8-diol is the precursor of the ultimate carcinogen, BaP-7,8-diol-9,10-epoxide (BaPDE). The ability of zCYP1A to bioactivate BaP was confirmed by the formation of DNA adducts when calf thymus DNA was added to the incubation mixture. BaP-DNA binding was enhanced by the addition of hEH to the incubation mixture. HPLC analysis of the [(33)P]-postlabeled DNA adducts showed the formation of at least four adducts mediated by both zCYP1A and trout liver microsomes, and one of these adducts co-migrated with BaPDE-dG in HPLC analysis. The addition of hEH to the incubation mixture decreased the formation of BaPDE-dG by zCYP1A and by trout liver microsomes while increasing the formation of an unidentified DNA adduct in the case of zCYP1A. zCYP1A also mediated the binding of BaP to protein, providing further evidence that this enzyme is capable of oxidizing BaP to reactive metabolites that bind to macromolecules. It thus appears that zCYP1A may play an important role in BaP-induced carcinogenesis in the zebrafish model by catalyzing the sequential formation of the ultimate diol epoxide carcinogenic metabolite of BaP.
Genes / Markers
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Engineered Foreign Genes